Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:NPD

(NPD) (NPD) Stock Price, News & Analysis

(NPD) logo

About (NPD) Stock (NYSE:NPD)

Advanced Chart

Key Stats

Today's Range
$2.55
$2.55
50-Day Range
N/A
52-Week Range
$2.00
$2.59
Volume
N/A
Average Volume
61,544 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

China Nepstar Chain Drugstore Ltd. is a retail drugstore chain in China. The Company provides its customers with pharmacy services and a range of other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products, including consumable, seasonal and promotional items. The Company operates through the retail drugstore business segment. The Company also offers private label products. It has a network of approximately 1,990 directly operated drugstores spanning over 70 cities across approximately 14 provinces and direct-controlled municipalities in China. The Company offers approximately 2,170 private label products. The Company also operates an Internet Website, www.star365.com. It offers approximately 3,210 prescription drugs. It offers approximately 3,360 over-the-counter drugs, including western medicines and traditional Chinese medicines, for the treatment of common diseases.

Receive NPD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (NPD) and its competitors with MarketBeat's FREE daily newsletter.

NPD Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
See More Headlines

NPD Stock Analysis - Frequently Asked Questions

(NPD) (NYSE:NPD) issued its earnings results on Wednesday, November, 25th. The company reported $0.00 EPS for the quarter. The business had revenue of $124.77 million for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that (NPD) investors own include Inovio Pharmaceuticals (INO), Avid Bioservices (CDMO), Corcept Therapeutics (CORT), Cardiome Pharma (CRME), CTI BioPharma (CTIC) and Sprott Focus Trust (FUND).

Company Calendar

Last Earnings
11/25/2015
Today
6/23/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
N/A
Industry
N/A
Sub-Industry
N/A
Current Symbol
NYSE:NPD
Web
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

This page (NYSE:NPD) was last updated on 6/23/2025 by MarketBeat.com Staff
From Our Partners